CollPlant Biotechnologies Ltd (CLGN) Form 6-K — Nov 2, 2026
CollPlant Biotechnologies announced that CEO Yehiel Tal will cease serving as CEO effective immediately, a determination made by the Board on November 2, 2026 in connection with a broader cost-reduction plan. Tal also resigned as Interim Chairman but will remain on the Board. The Board appointed Eran Rotem, previously Deputy CEO and CFO, as Chief Executive Officer. Rotem will continue to serve as CFO with his compensation terms unchanged.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.